Turning Point Brands Reports Q4 2025 Results, Shares Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 13 hours ago
0mins
Should l Buy TPB?
Source: Benzinga
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPB
Wall Street analysts forecast TPB stock price to fall
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 136.990
Low
110.00
Averages
116.67
High
120.00
Current: 136.990
Low
110.00
Averages
116.67
High
120.00
About TPB
Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products. It sells a range of products to adult consumers, consisting of staple products under the brands Zig-Zag and Stoker’s. Its segments include Zig-Zag Products (Zig-Zag) and Stoker’s Products (Stoker’s). Zig-Zag principally markets and distributes rolling papers, tubes, and related products; finished cigars and make-your-own cigar wraps, and other accessories. It introduced Zig-Zag ‘Rillo-sized wraps, which are similar in size to cigarillos, a type of machine-made cigars. Stoker’s manufactures and markets moist snuff tobacco (MST) and contract for and market FRE, its modern oral product and contract for and market loose-leaf chewing tobacco products. Its products are available in approximately 200,000 in the United States retail locations which, with the addition of retail stores in Canada, brings its total North American retail presence to an estimated 220,000 points of distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
Turning Point Brands Reports Q4 Earnings Decline Amid Strategic Shift
- Significant Sales Growth: Turning Point Brands reported a 29% increase in sales for Q4, with adjusted earnings per share dipping 3%, yet both metrics surpassed Wall Street expectations, indicating the company's competitive strength during its transition.
- Profitability Challenges: Management anticipates a 15% sequential decline in adjusted EBITDA, reflecting the challenges faced during the shift from traditional smoking accessories to white nicotine pouches, leading the market to adopt a wait-and-see approach.
- Surge in Nicotine Pouch Sales: Sales of nicotine pouches soared by 266% in Q4, accounting for 34% of total sales, up from 12% last year, highlighting the company's successful pivot to new product lines that are expected to become major revenue sources.
- Rising Costs Impacting Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and causing a decline in profitability, indicating the pressure from investments in marketing and new production capabilities.
See More
Turning Point Reports 29% Sales Growth in Q4 Amid Earnings Dip
- Significant Sales Growth: Turning Point's sales increased by 29% in Q4, while adjusted earnings per share dipped by 3%, surpassing Wall Street expectations and indicating strong market demand during the company's transition.
- Surge in Nicotine Pouch Sales: Nicotine pouch sales soared by 266% in Q4, accounting for 34% of total sales, up from just 12% last year, demonstrating the company's successful expansion of its distribution network and potential as a primary revenue source.
- Rising Costs Impact Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and leading to a decline in profitability, reflecting the cost pressures faced during the transition.
- Optimistic Market Outlook: Although shares fell by 20%, the market remains cautiously optimistic about Turning Point's future, with the nicotine pouch market projected to grow by at least 20% over the next five years, as the company actively adjusts its strategy to align with this trend.
See More
U.S. Stocks Mixed Amid Iran-U.S. Conflict; Energy Shares Rise
- Mixed Market Performance: U.S. stocks exhibited mixed performance amid the ongoing Iran-U.S. conflict, with the Dow Jones index falling 0.1% to 48,929.19 while the NASDAQ gained 0.37% to 22,751.80, indicating a complex market sentiment.
- Energy Sector Gains: Energy shares rose by 1.8% on Monday, reflecting optimistic expectations for energy demand despite the overall mixed market performance, suggesting strong investor confidence in the energy sector.
- Sealed Air Earnings Beat: Sealed Air Corp (NYSE:SEE) reported fourth-quarter earnings of 77 cents per share, exceeding analyst expectations of 73 cents, with quarterly sales reaching $1.401 billion, surpassing the forecast of $1.342 billion, demonstrating the company's robust profitability.
- International Market Fluctuations: European markets declined broadly, with the STOXX 600 falling 1.65%, reflecting global economic uncertainties, while Asian markets mostly closed lower, indicating investor concerns about future economic prospects.
See More
Turning Point Brands Reports Strong Q4 2025 Earnings and Growth Outlook
- Significant Revenue Growth: Turning Point Brands reported fourth-quarter revenue of $121 million for 2025, reflecting a 29% year-over-year increase, with Modern Oral net revenue at $41.3 million, indicating strong market demand and brand appeal that is expected to drive future performance.
- EBITDA Increase: Adjusted EBITDA reached $30 million, a 14% year-over-year growth, with a gross margin of 55.9% remaining flat, showcasing the company's resilience in profitability despite investment pressures, reflecting effective cost control and operational efficiency.
- 2026 Outlook: The company initiated guidance for Modern Oral sales between $220 million and $240 million, with net sales guidance of $180 million to $190 million, indicating management's confidence in future growth while planning to increase investments in sales and marketing to support new product launches.
- Strategic Investment Plans: Management emphasized ongoing significant investments in white pouch brands, including increasing sales force, optimizing online presence, and international expansion, which not only aids in increasing market share but also enhances the brand's long-term competitiveness.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
Turning Point Brands Reports Q4 Earnings Decline Amid Strategic Shift
- Significant Sales Growth: Turning Point Brands reported a 29% increase in sales for Q4, with adjusted earnings per share dipping 3%, yet both metrics surpassed Wall Street expectations, indicating the company's competitive strength during its transition.
- Profitability Challenges: Management anticipates a 15% sequential decline in adjusted EBITDA, reflecting the challenges faced during the shift from traditional smoking accessories to white nicotine pouches, leading the market to adopt a wait-and-see approach.
- Surge in Nicotine Pouch Sales: Sales of nicotine pouches soared by 266% in Q4, accounting for 34% of total sales, up from 12% last year, highlighting the company's successful pivot to new product lines that are expected to become major revenue sources.
- Rising Costs Impacting Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and causing a decline in profitability, indicating the pressure from investments in marketing and new production capabilities.
See More
Turning Point Reports 29% Sales Growth in Q4 Amid Earnings Dip
- Significant Sales Growth: Turning Point's sales increased by 29% in Q4, while adjusted earnings per share dipped by 3%, surpassing Wall Street expectations and indicating strong market demand during the company's transition.
- Surge in Nicotine Pouch Sales: Nicotine pouch sales soared by 266% in Q4, accounting for 34% of total sales, up from just 12% last year, demonstrating the company's successful expansion of its distribution network and potential as a primary revenue source.
- Rising Costs Impact Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and leading to a decline in profitability, reflecting the cost pressures faced during the transition.
- Optimistic Market Outlook: Although shares fell by 20%, the market remains cautiously optimistic about Turning Point's future, with the nicotine pouch market projected to grow by at least 20% over the next five years, as the company actively adjusts its strategy to align with this trend.
See More
U.S. Stocks Mixed Amid Iran-U.S. Conflict; Energy Shares Rise
- Mixed Market Performance: U.S. stocks exhibited mixed performance amid the ongoing Iran-U.S. conflict, with the Dow Jones index falling 0.1% to 48,929.19 while the NASDAQ gained 0.37% to 22,751.80, indicating a complex market sentiment.
- Energy Sector Gains: Energy shares rose by 1.8% on Monday, reflecting optimistic expectations for energy demand despite the overall mixed market performance, suggesting strong investor confidence in the energy sector.
- Sealed Air Earnings Beat: Sealed Air Corp (NYSE:SEE) reported fourth-quarter earnings of 77 cents per share, exceeding analyst expectations of 73 cents, with quarterly sales reaching $1.401 billion, surpassing the forecast of $1.342 billion, demonstrating the company's robust profitability.
- International Market Fluctuations: European markets declined broadly, with the STOXX 600 falling 1.65%, reflecting global economic uncertainties, while Asian markets mostly closed lower, indicating investor concerns about future economic prospects.
See More
Turning Point Brands Reports Strong Q4 2025 Earnings and Growth Outlook
- Significant Revenue Growth: Turning Point Brands reported fourth-quarter revenue of $121 million for 2025, reflecting a 29% year-over-year increase, with Modern Oral net revenue at $41.3 million, indicating strong market demand and brand appeal that is expected to drive future performance.
- EBITDA Increase: Adjusted EBITDA reached $30 million, a 14% year-over-year growth, with a gross margin of 55.9% remaining flat, showcasing the company's resilience in profitability despite investment pressures, reflecting effective cost control and operational efficiency.
- 2026 Outlook: The company initiated guidance for Modern Oral sales between $220 million and $240 million, with net sales guidance of $180 million to $190 million, indicating management's confidence in future growth while planning to increase investments in sales and marketing to support new product launches.
- Strategic Investment Plans: Management emphasized ongoing significant investments in white pouch brands, including increasing sales force, optimizing online presence, and international expansion, which not only aids in increasing market share but also enhances the brand's long-term competitiveness.
See More
